Blonyx Biosciences Ltd. LONDON


Founded in 2016, Blonyx Biosciences, classified under reg no. 10154031 is an active company. Currently registered at 8 Imperial Road N22 8DE, London the company has been in the business for 10 years. Its financial year was closed on Thu, 30th Apr and its latest financial statement was filed on April 30, 2022.

The company has 3 directors, namely Lindsay M., Frances M. and Rowan M.. Of them, Rowan M. has been with the company the longest, being appointed on 28 April 2016 and Lindsay M. and Frances M. have been with the company for the least time - from 3 February 2025. As of 11 February 2026, our data shows no information about any ex officers on these positions.

Blonyx Biosciences Ltd. Address / Contact

Office Address 8 Imperial Road
Town London
Post code N22 8DE
Country of origin United Kingdom

Company Information / Profile

Registration Number 10154031
Date of Incorporation Thu, 28th Apr 2016
Industry Manufacture of other food products n.e.c.
End of financial Year 30th April
Company age 10 years old
Account next due date Wed, 31st Jan 2024 (742 days after)
Account last made up date Sat, 30th Apr 2022
Next confirmation statement due date Thu, 8th Feb 2024 (2024-02-08)
Last confirmation statement dated Wed, 25th Jan 2023

Company staff

Lindsay M.

Position: Director

Appointed: 03 February 2025

Frances M.

Position: Director

Appointed: 03 February 2025

Rowan M.

Position: Director

Appointed: 28 April 2016

People with significant control

The register of PSCs that own or control the company consists of 3 names. As we identified, there is Lindsay M. The abovementioned PSC and has 25-50% shares. Another one in the PSC register is Frances M. This PSC owns 25-50% shares. Moving on, there is Rowan M., who also meets the Companies House criteria to be categorised as a PSC. This PSC owns 25-50% shares.

Lindsay M.

Notified on 4 February 2025
Nature of control: 25-50% shares

Frances M.

Notified on 4 February 2025
Nature of control: 25-50% shares

Rowan M.

Notified on 28 April 2016
Nature of control: 25-50% shares

Annual reports financial information

Profit & Loss
Accounts Information Date 2017-04-302018-04-302019-04-302020-04-302021-04-302022-04-302023-04-302024-04-30
Net Worth-158       
Balance Sheet
Current Assets36 56425 66221 55919 97613 12411 3506 0999 576
Net Assets Liabilities -919-4 389-2 555-2 274-4 118-11 765-19 465
Net Assets Liabilities Including Pension Asset Liability-158       
Reserves/Capital
Shareholder Funds-158       
Other
Called Up Share Capital Not Paid Not Expressed As Current Asset1010101010101010
Creditors 26 59125 95822 54115 40815 47817 87429 051
Depreciation Amortisation Impairment Expense   1 5465362 22078 
Net Current Assets Liabilities-168-929-4 399-2 565-2 284-4 128-11 775-19 475
Other Operating Expenses Format2   51 71061 86526 41127 00630 181
Other Operating Income Format2   54 31  
Profit Loss   1 834282-1 845-7 646-7 711
Raw Materials Consumables Used   14 24236 2468 54112 31110 791
Staff Costs Employee Benefits Expense   2 2012 843828520195
Total Assets Less Current Liabilities-158-919-4 389-2 555-2 27411 3606 109-19 465
Turnover Revenue   71 479101 77236 12432 26933 456
Creditors Due Within One Year36 732       

Company filings

Filing category
Accounts Capital Confirmation statement Incorporation Officers Persons with significant control
Confirmation statement with updates February 11, 2025
filed on: 11th, February 2025
Free Download (4 pages)

Company search

Advertisements